Acta Clin Croat 2013; 52:195-202 Review PERIPHERAL FACIAL WEAKNESS (BELL’S PALSY)

SUMMARY – Peripheral facial weakness is a facial nerve damage that results in muscle we-akness on one side of the face. It may be idiopathic (Bell’s palsy) or may have a detectable cause. Almost 80 % of peripheral facial weakness cases are primary and the rest of them are secondary. The most frequent causes of secondary peripheral facial weakness are systemic viral infections, trauma, surgery, diabetes, local infections, tumor, immune disorders, drugs, degenerative diseases of the central nervous system, etc. The diagnosis relies upon the presence of typical signs and symptoms, blood chemistry tests, cerebrospinal fluid investigations, nerve conduction studies and neuroima-ging methods (cerebral MRI, x-ray of the skull and mastoid). Treatment of secondary peripheral facial weakness is based on therapy for the underlying disorder, unlike the treatment of Bell’s palsy that is controversial due to the lack of large, randomized, controlled, prospective studies. There are some indications that steroids or antiviral agents are beneficial but there are also studies that show no beneficial effect. Additional treatments include eye protection, physiotherapy, acupuncture, bo-tulinum toxin, or surgery. Bell’s palsy has a benign prognosis with complete recovery in about 80% of patients, 15 % experience some mode of permanent nerve damage and severe consequences remain in 5 % of patients